TrialBlood advances2018

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia.

Brian Ball et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.